SUSQUEHANNA INTERNATIONAL GROUP, LLP - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$5,416,341
+57.4%
1,289,605
+125.2%
0.00%0.0%
Q4 2022$3,441,951
-65.3%
572,704
-66.4%
0.00%
-66.7%
Q3 2022$9,906,000
+118.9%
1,701,992
+124.6%
0.00%
Q2 2022$4,525,000
-20.3%
757,924
-37.6%
0.00%
-100.0%
Q1 2022$5,674,000
+15.0%
1,214,844
-39.0%
0.00%
Q4 2021$4,936,000
+292.7%
1,990,652
+367.3%
0.00%
Q3 2021$1,257,000
+36.6%
425,993
+15.7%
0.00%
Q2 2021$920,000
-34.5%
368,100
-23.7%
0.00%
Q1 2021$1,405,000
-13.2%
482,740
-3.9%
0.00%
Q4 2020$1,618,000
+196.9%
502,198
+98.1%
0.00%
Q3 2020$545,000
+2625.0%
253,500
+1382.5%
0.00%
Q2 2020$20,000
+53.8%
17,100
+21.3%
0.00%
Q1 2020$13,000
-89.1%
14,100
-81.2%
0.00%
Q4 2019$119,000
+283.9%
75,000
+98.9%
0.00%
Q3 2019$31,000
-94.0%
37,700
-93.7%
0.00%
Q2 2019$516,000
+386.8%
601,800
+452.5%
0.00%
Q1 2019$106,000
+1077.8%
108,931
+751.0%
0.00%
Q4 2018$9,000
-74.3%
12,800
-20.5%
0.00%
Q3 2018$35,000
-89.6%
16,100
-76.1%
0.00%
Q2 2018$335,000
-57.8%
67,300
-67.0%
0.00%
Q1 2018$794,000
+615.3%
203,684
+389.2%
0.00%
Q4 2017$111,000
-34.3%
41,640
-21.6%
0.00%
Q3 2017$169,000
-84.7%
53,100
-84.1%
0.00%
Q2 2017$1,103,000
+271.4%
333,236
+372.0%
0.00%
Q1 2017$297,00070,6000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders